Brian J. Brille files SEC Form 4 disclosures for Caris Life Sciences, Inc.. They have made 2 open-market trades across 1 company since 2025, most recently 2026-09-17.
CIK 0002071959
1 open-market purchase totalling $630K since 2025, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CAI | 230,303 | $7.0M |
Shares reported on the most recent Form 4, priced at the 2026-09-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.